Latest Insider Transactions at New Amsterdam Pharma CO N.V. (NAMS)
This section provides a real-time view of insider transactions for New Amsterdam Pharma CO N.V. (NAMS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NewAmsterdam Pharma Co N.V. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NewAmsterdam Pharma Co N.V.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 01
2024
|
Louise Frederika Kooij Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
45,000
-100.0%
|
$675,000
$15.72 P/Share
|
|
Sep 27
2024
|
Louise Frederika Kooij Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
45,000
+50.0%
|
-
|
|
Sep 26
2024
|
Juliette Berangere Audet Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
1,104
+50.0%
|
$16,560
$15.7 P/Share
|
|
Aug 20
2024
|
Michael H. Davidson Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+2.33%
|
$80,000
$16.27 P/Share
|
|
Jun 20
2024
|
Michael H. Davidson Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+2.38%
|
$85,000
$17.26 P/Share
|
|
Mar 26
2024
|
James N Topper |
BUY
Open market or private purchase
|
Indirect |
8,429
+0.28%
|
$177,009
$21.5 P/Share
|
|
Mar 26
2024
|
Johannes Jacob Pieter Kastelein Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
190,476
-100.0%
|
$3,999,996
$21.5 P/Share
|
|
Mar 26
2024
|
Johannes Jacob Pieter Kastelein Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Indirect |
11,197
-5.55%
|
$246,334
$22.72 P/Share
|
|
Mar 26
2024
|
Johannes Jacob Pieter Kastelein Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
201,673
+50.0%
|
-
|
|
Feb 13
2024
|
Louis G Lange |
BUY
Open market or private purchase
|
Indirect |
5,000
+16.73%
|
$95,000
$19.0 P/Share
|